Zhi Xiao Ling Tablets
Natural health product licensed in Canada
- Other names
- Nasal Congestion Relief, Xiao Zhi Xiao Ling Tablets
- Licence holder
- 11753649 Canada Inc. (6 Degrees Holdings)
- NPN or DIN-HM
- 80129451
- Status
- Active licence
- Licence date
- 9 February 2024
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Dictamnus dasycarpus Extract : Matériel brut sec Extraction ratio : 4.762:1 Dry plant equivalent : 10 mg | 2.1 mg | Not calculated |
Non-medicinal ingredients
Sucrose, Talc, Cire d'Ericerus pela, Amidon de maïs, Stéarate de magnésium, Tartrazine, Saveur de pêche
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 8 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine as a decongestant/to relieve nasal congestion (due to hay fever/allergic rhinitis/allergies/sinusitis/the common cold/flu). Combination of Traditional Chinese Medicine Ingredients (Cacumen Platycladi, Exocarpium Rubrum Citri Reticulatae, Radix Scutellariae, Radix et Rhizoma Glycyrrhizae, Bulbus Fritillariae Cirrhosae, Batryticatus Bombyx, Pheretima, Radix Sophorae Flavescentis, Rhizoma Belamcandae, Cortex Dictamni, Fructus Perillae, Siphonostegiae Herba, Radix et Rhizoma Asari, Borneolum Syntheticum).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80129451
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.